Compass Pathways PlcEquity-NMS: CMPS
Equity-NMS: CMPS
$12.38
+0.67
(28 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$12.38
Open
$12.38
Today’s high
$12.75
Today’s low
$11.34
52W low
$5.01
52W high
$12.75
1Y
50.06%
Shares O/S
61.88M
Market cap
766.13M
Insights
CMPS has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
CMPS price is below its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Compass Pathways Plc

COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin.

The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. This trial assessed the safety and efficacy of COMP360 psilocybin therapy in three doses: 1mg, 10mg, 25mg. The Company is also running a Phase II clinical trial of COMP360 psilocybin therapy for anorexia nervosa and post-traumatic stress disorder (PTSD). The Company is also developing its investigational COMP360 psilocybin therapy for the treatment of a range of mental health conditions, with an initial focus on TRD. .


FAQs

Can I buy Compass Pathways Plc shares in India?
How to buy Compass Pathways Plc shares in India?
What is the share price of Compass Pathways Plc?
What is the Market Capitalization of Compass Pathways Plc?
What is the PE ratio of Compass Pathways Plc?
Is Compass Pathways Plc a good stock to buy?
In which sector / industry does Compass Pathways Plc operate?